A watchdog on Thursday said that Rep. Chris Collins may have broken federal law when he took actions to help a biotech in which he held a big stake.
Latest posts by Market Watch (see all)
- Berkshire Hathaway gives Buffett and Munger more flexibility on stock buybacks - July 17, 2018
- Alphabet removes Nest CEO, says report - July 17, 2018
- Mark Hulbert: Gold is still dazzling market timers — and that’s bearish - July 17, 2018